Verification evidence is still being completed.
Biovica
Uppsala, Sweden
- Verified lead
- Anders Rylander
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays
- Review cycle
- May 2026
- Full address
- Dag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Biovica contact page confirming the Uppsala address.
- Editorial note
- Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.
Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays
Official leadership disclosure, Official Uppsala contact disclosure, Oncology diagnostics platform claim
Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.
Biovica
Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays · Commercial diagnostics platform
Biovica runs cancer monitoring, biomarker assays, and oncology diagnostics in Uppsala, Sweden.
- Lead
- Anders Rylander (verified ↗)
- Address
- Dag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial diagnostics platform
- Capabilities
- Cancer Monitoring · Biomarker Assays · Oncology Diagnostics
- Founded
- 2006
- Headcount
- 11-50
- Company page (open ↗)
Anders Rylander
CEO
Commercial diagnostics platform
Uppsala, Sweden. Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays. Review completed on 21 Mar 2026.
Swedish corporate and diagnostics oversight
Official leadership disclosure, Official Uppsala contact disclosure, Oncology diagnostics platform claim
Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays
Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.
Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Biovica located?
- Biovica operates from Dag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden, Uppsala, Sweden.
- Who runs Biovica?
- Biovica is led by Anders Rylander, CEO. Verified 21 Mar 2026.
- What does Biovica do?
- Biovica runs cancer monitoring, biomarker assays, and oncology diagnostics in Uppsala, Sweden. Core capabilities: Cancer Monitoring, Biomarker Assays, Oncology Diagnostics.
Related technical briefs
Briefs that name Uppsala as a covered market or city.
